Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Conference News NY Valves 2025

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Yael L. Maxwell

July 03, 2025

News Conference News NY Valves 2025

Global Burden of Degenerative Mitral Valve Disease Continues to Rise

Todd Neale

June 30, 2025

Presentation NY Valves 2025

Posterior Leaflet Restoration to Reduce Secondary MR Using the MRace System (EXPLORE MR): Early Feasibility Experience (Polares)

Presenter: Fabio Sandoli de Brito

June 26, 2025

Presentation NY Valves 2025

Early Feasibility Experience of Posterior Leaflet Restoration to Reduce Secondary MR Using the MRace Implant (EXPLORE MR)

Presenter: Fabio Sandoli de Brito

June 25, 2025

Presentation NY Valves 2025

Mitral TEER in Symptomatic FMR: Emerging Data and Futuristic Trends

Presenter: Gregg W. Stone

June 25, 2025

Presentation NY Valves 2025

Optimizing Mitral TEER in FMR: Technical and Device Strategies

Presenter: Jörg Hausleiter

June 25, 2025

Presentation NY Valves 2025

Case Resolution: A Symptomatic Patient With Moderate to Severe MR

Presenter: Fahad Gilani

June 25, 2025

Presentation NY Valves 2025

GDMT in FMR: What Every Interventionalist Needs to Know

Presenter: Sean P. Pinney

June 25, 2025

Presentation NY Valves 2025

Phenotyping of FMR: Imaging Classification, Severity Assessment, and Parameters for Futility

Presenter: Federico M. Asch

June 25, 2025

Presentation NY Valves 2025

Case Presentation: A Symptomatic Patient With Moderate to Severe MR

Presenter: Fahad Gilani

June 25, 2025

News Conference News NY Valves 2024

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

Michael O'Riordan

June 10, 2024

Presentation NY Valves 2024

CON: TMVR Has too Many Problems – Just Do M-TEER

Presenter: Saibal Kar

June 06, 2024

Presentation NY Valves 2024

PRO: TMVR Is a Good Option for Functional MR

Presenter: Chet Rihal

June 06, 2024

Presentation NY Valves 2024

Treatment Options for Functional MR: ADVANCED GDMT, M-TEER, TMVR, and Surgery – What Does the Evidence Show?

Presenter: Javed Butler

June 06, 2024

Presentation NY Valves 2024

CON: M-TEER for ALL Phenotypes – Symptomatic Improvement Is Enough

Presenter: Michael Joseph Rinaldi

June 06, 2024

Presentation NY Valves 2024

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

Presenter: JoAnn Lindenfeld

June 06, 2024

Presentation NY Valves 2024

The Heterogeneity of Functional MR: Phenotype Clusters and Implications for Management

Presenter: Anna Sannino

June 06, 2024

Presentation NY Valves 2024

Secondary MR and GDMT Titration Before M-TEER in the Real-world

Presenter: Donna Mancini

June 05, 2024

Video

» Interview

Has Modern-Era GDMT Changed the Need for Mitral TEER in Secondary MR?

June 24, 2024

Advertisement

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Global Burden of Degenerative Mitral Valve Disease Continues to Rise

Posterior Leaflet Restoration to Reduce Secondary MR Using the MRace System (EXPLORE MR): Early Feasibility Experience (Polares)

Early Feasibility Experience of Posterior Leaflet Restoration to Reduce Secondary MR Using the MRace Implant (EXPLORE MR)

Mitral TEER in Symptomatic FMR: Emerging Data and Futuristic Trends

Optimizing Mitral TEER in FMR: Technical and Device Strategies

Case Resolution: A Symptomatic Patient With Moderate to Severe MR

GDMT in FMR: What Every Interventionalist Needs to Know

Phenotyping of FMR: Imaging Classification, Severity Assessment, and Parameters for Futility

Case Presentation: A Symptomatic Patient With Moderate to Severe MR

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

CON: TMVR Has too Many Problems – Just Do M-TEER

PRO: TMVR Is a Good Option for Functional MR

Treatment Options for Functional MR: ADVANCED GDMT, M-TEER, TMVR, and Surgery – What Does the Evidence Show?

CON: M-TEER for ALL Phenotypes – Symptomatic Improvement Is Enough

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

The Heterogeneity of Functional MR: Phenotype Clusters and Implications for Management

Secondary MR and GDMT Titration Before M-TEER in the Real-world

Has Modern-Era GDMT Changed the Need for Mitral TEER in Secondary MR?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content